Being required for ERα function, high levels of CREB1 may contribute to prevent a tumorigenic evolution, notably for cancers that have not yet been treated with tamoxifen, toward more aggressive and therapy-resistant versions of breast cancer that are estrogen and ERα independent. Here, ESR1 is linked to breast carcinoma.